No products in the cart.
Compound L?Aspartate L?Ornithine Granules 3?g (Rigan) – Wholesale & Research Use
$1.00
Rigan Compound L?Aspartate L?Ornithine Granules provide 3?g per sachet, with 21 sachets per box. Manufactured by Wuhan Qirui Pharmaceutical Co., Ltd., and approved under NMPA H20090160. Designed for research into hyperammonemia, liver support, and metabolic detoxification.
?? For laboratory or research use only. ?Please consult staff for other specifications and uses?
Description
This granule formulation combines the amino acids L?aspartate and L?ornithine to support hepatic ammonia detoxification via the urea cycle. Commonly used in preclinical research on liver disease, encephalopathy prevention, and metabolic liver protection. Dissolve each sachet in water or juice and administer orally under controlled experimental conditions.
Product Specifications
| Parameter | Details |
|---|---|
| Product Name | Compound L?Aspartate L?Ornithine Granules (Rigan) |
| Active Ingredients | L?Aspartate, L?Ornithine |
| CAS Numbers | L?Aspartate: 56?84?8; L?Ornithine: 70?26?8 |
| Formulation | Oral granules |
| Dosage per Sachet | 3?g |
| Quantity per Box | 21 sachets |
| Dosage Form | Powder for oral suspension |
| NMPA Approval No. | H20090160 |
| Drug Standard Code | 86901957000047 |
| Manufacturer | Wuhan Qirui Pharmaceutical Co., Ltd. |
| Barcode | Not yet assigned; contact pharmacist |
| Shelf Life | 30 months |
| Storage Conditions | Store below 25?°C, in dry, light?protected area |
| Intended Use | Research into hepatic hyperammonemia and liver support |
Product appears as a white or off-white granule with a slightly sweet-sour taste.
Mechanism of Action
L?Ornithine and L?Aspartate enhance ammonia detoxification by activating the urea cycle and promoting glutamine synthesis, thereby reducing circulating blood ammonia—a key factor in hepatic encephalopathy.
Research & Application Areas
Hyperammonemia management in acute and chronic liver disease models
Hepatic encephalopathy prevention studies
Non?alcoholic fatty liver disease (NAFLD) research
Urea cycle support and nitrogen metabolism experiments
Comparative studies with intravenous formulations
Studies show oral L?ornithine?L?aspartate granules are effective and safe, improving liver enzyme profiles and reducing ammonia levels in metabolic liver disorders
Safety & Handling
Adverse Effects: Rare mild nausea, vomiting, or bloating; symptoms typically resolve upon discontinuation .
Contraindications: Allergy to amino acids or severe renal impairment (serum creatinine >3 mg/dL).
Administration: Dissolve granule in water/juice, take 1–3 times daily (usually 3?g each dose), post-meal. Dosing may be adjusted based on experimental protocol.
Handling: Use gloves and lab coat; avoid ingestion outside research contexts.
Storage: Store granules sealed and protected from moisture and light.
Core Keywords
aspartate ornithine granules, H20090160, hyperammonemia research, urea cycle support, liver detox granules, Rigan granules wholesale, research-grade ornithine aspartate
Research Use Disclaimer
This product is for research and experimental use only. Not approved for therapeutic, diagnostic, or clinical applications. Misuse may pose health or legal risks. Use only under institutional oversight and according to local regulations.
Additional information
| Weight | 1 kg |
|---|---|
| Dimensions | 26 × 23 × 26 cm |
Related products
N?Acetylcysteine Injection 4?g (Minsheng / Asixintai)
Minsheng (Asixintai) N?Acetylcysteine Injection delivers 4?g per 20?ml vial in a sterile solution. Manufactured by Hangzhou Minsheng Pharmaceutical Co., Ltd., approved under NMPA H20051788. Widely used in preclinical research for hepatoprotective, antioxidant, and mucolytic applications.
?? For laboratory and research use only.?Please consult staff for other specifications and uses? $1.00Compound Ammonium Glycyrrhetate (Yingtiancheng) Low price wholesale
Yingtiancheng Compound Ammonium Glycyrrhetate Injection offers a hepatoprotective formula in 5 vials of 20?ml each. Produced by Hebei Tiancheng Pharmaceutical Co., Ltd., approved under NMPA H13023812. Ideal for lab studies involving liver function, inflammation, and oxidative stress.?? For laboratory research use only. Not for clinical or therapeutic use.?Please consult staff for other specifications and uses? $2.00Adenosine Disodium Triphosphate Injection 10?mg /?1?ml × 5 Ampoules (Nalü) – Wholesale & Laboratory Use
Nalü Adenosine Disodium Triphosphate Injection contains 10?mg ATP per 1?ml sterile ampoule, packaged as 5 ampoules per box. Manufactured by Shanxi Duns Pharmaceutical Co., Ltd. and approved under NMPA H61021839. Ideal for lab research in ischemia-reperfusion, metabolic support, cardiovascular models, and mitochondrial studies.
?? For laboratory and research use only.?Please consult staff for other specifications and uses? $2.00Adenosylmethionine Disulfate Tosylate Injection 0.5?g ×?5 Vials (Baixino) – Wholesale & Laboratory Use
Baixino Adenosylmethionine Disulfate Tosylate Injection contains 0.5?g SAMe per vial (plus solvent). Manufactured by CSPC Tianqing Pharmaceutical Group Co., Ltd., approved under NMPA H20193344. Commonly used in laboratory studies of liver protection, methylation pathways, and cholestatic liver disorders.
?? For laboratory and research use only.?Please consult staff for other specifications and uses? $1.00
Reviews
There are no reviews yet.